The U.S. National Institute on Drug Abuse (NIDA), part of the Department of Health and Human Services' National Institutes of Health, awarded a $19,600.00 Purchase Order contract to Lin Jiunn, a small business located in Ambler, Pennsylvania. The contract is for a Subject Matter Expert Consultant in Drug Metabolism Pharmacokinetics (DMPK) to support NIDA's NIH Blueprint Neurotherapeutics Network program. The contract has a one-year base period with an estimated minimum of 20 annual hours and a...
<p>This is a $531,600.00 Purchase Order contract awarded by the National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency, to Pearson Pharma Partners, a for-profit S Corporation. The contract is for a Subject Matter Expert Consultant to provide services related to Drug Metabolism Pharmacokinetics (DMPK) and has a period of performance through June 30, 2025. The contract was awarded on a labor hours pricing basis and does not have a set-aside designation.</p>
This federal contract award was issued by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The contract was awarded to JP Lawson Consulting, a small business, to provide process chemistry consultant services to support the NIH Blueprint Neurotherapeutics Network (BPN) drug discovery and development programs. The contract is a Labor Hours Purchase Order with a ceiling value of...
The Department of Health and Human Services National Institutes of Health National Institute of Neurological Disorders and Stroke awarded a $532,500 purchase order to Pearson Pharma Partners of Thousand Oaks, California for Drug Metabolism and Pharmacokinetics (DMPK) Consulting Support Services. The contract is set aside for small businesses and will provide senior-level DMPK consultants to advise the Blueprint Neurotherapeutics Program and other NIH neuroscience initiatives on study design,...
<p>The National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a $24,900 firm fixed price purchase order contract to Pelago Bioscience AB, a for-profit limited liability company. The contract is for the development of a new assay to test compounds of interest. The period of performance runs from the award date of September 9, 2024 through September 8, 2025. This contract award does not have a set-aside designation.</p>
This is a $245,400 firm-fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services (HHS), to RPK Associates, LLC, a small business, for biological therapeutics product development subject matter expert consulting services. The contract supports the development of therapeutic biotechnology products (biologics) and includes option periods through November 16, 2025. The contract was awarded...
The National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a $382,010.00 Firm Fixed Price Delivery Order contract to Vitae Enim Vitae Scientific, Inc. (VEV Scientific) on September 27, 2024. The contract is for dosage form reprocessing and stability studies of the FX-5A injection drug product under an Indefinite Delivery/Indefinite Quantity (IDIQ) contract for Chemistry, Manufacturing and Controls (CMC) and related services to support drug product development. The contract...
This federal contract award is a delivery order under a larger contract vehicle, with Research Triangle Institute (RTI) International as the prime contractor. The contract is with the National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services (HHS). The award, valued at $376,358.00, is for the synthesis and distribution of drugs of abuse and related compounds over a one-year period from June 16, 2024 to June 15, 2025, with a total period of...
The National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services (HHS), awarded a $12,645.00 Firm Fixed Price Delivery Order contract to JP Lawson Consulting, a small business, to provide consulting services under the Drug Consulting Blueprint Network contract vehicle. The contract has no set-aside designation and was awarded on September 21, 2018 with a final completion date of September 27, 2019. JP Lawson Consulting is the sole...
This federal contract award is for $506,948.00 and was issued by the National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services (HHS). The contract was awarded to JM Sisco Pharma Consulting, LLC, a small business entity, to administratively de-obligate unexpended and expiring fiscal year 2020 funding in preparation for the closing of the period of availability for these funds. The contract was set aside for total small business and was awarded...